NIOX Group plc
("NIOX" or the "Company")
Director/PDMR Shareholding
Oxford, UK - 1 April 2025: NIOX Group plc (AIM: NIOX) announces it has today issued 363,006 new ordinary shares in the Company ("Ordinary Shares") to its Executive Directors under the Company's Deferred Share Bonus Plan (the "Plan").
The share issue was made in respect of the annual bonus for the 2022 financial year, which was granted on 28 March 2023. Under the terms of the company's remuneration policy, 75% of this bonus was deferred for two years, other than for the sale of shares to satisfy any tax liability created on grant. The allotment of shares took place today following the release of the Company's year-end results earlier this morning, which marks the end of the Company's closed period.
The 363,006 new Ordinary Shares issued in connection with these awards are subject to an existing block admission for the respective Plan and rank pari passu with the Company's existing Ordinary Shares.
The number of Ordinary Shares that were today allotted to each Executive Director and their resultant interest in the Company is as follows:
| | Number of Ordinary Shares issued | Resulting number of Ordinary Shares held | Resulting interest in the Company |
| Ian Johnson | 136,558 | 1,071,069 | 0.26% |
| Jonathan Emms | 127,454 | 1,069,123 | 0.26% |
| Michael Roller | 98,994 | 800,852 | 0.20% |
Voting rights
Following the above, the Company's issued share capital comprises 408,343,556 Ordinary Shares, 398,343,556 Ordinary Shares with equal voting rights, and 10,000,000 shares held in Treasury. This figure of 398,343,556 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure, Guidance and Transparency Rules.
Additional details are provided below in accordance with the requirements of UK MAR.
| For further information, please contact: | |
|
NIOX Group plc Ian Johnson, Executive Chairman Michael Roller, Chief Financial Officer Sarah Duncan, Company Secretary
|
+44 (0) 3303 309 356
|
| Singer Capital Markets (Nominated Adviser and Joint Broker) Jen Boorer / James Fischer / James Todd
| +44 (0) 20 7496 3000 |
| Investec Bank plc (Financial Adviser and Joint Broker) Ben Lawrence / Lydia Zychowska | +44 (0) 20 7597 4000 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a. | Name | 1. Ian Johnson 2. Jonathan Emms 3. Michael Roller | ||||
| 2. | Reason for the notification | |||||
| a. | Position/status | 1. Executive Chairman 2. Chief Executive Officer 3. Chief Financial Officer | ||||
| b. | Initial notification /Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a. | Name | NIOX Group plc | ||||
| b. | LEI | 2138006YAT138TOGA556 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary Shares of 0.08p each
GB00BJVD3B28 | ||||
| b. | Nature of the transaction |
Issue of new Ordinary Shares under the Deferred Share Bonus Plan | ||||
| c. | Price(s) and volume(s) |
| ||||
| d. | Aggregated information · Aggregated volume · Price
|
n/a
| ||||
| e. | Date of the transaction | 01/04/2025 | ||||
| f. | Place of the transaction | London Stock Exchange, AIM
| ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.